Humedix Co., Ltd. (KOSDAQ:200670)

Market Cap	297.22B -27.5%
Revenue (ttm)	110.99B +12.7%
Net Income	9.06B -39.9%
EPS	963.99 -39.3%
Shares Out	10.32M
PE Ratio	29.88
Forward PE	7.32
Dividend	1,120.00 (3.89%)
Ex-Dividend Date	May 26, 2026

Volume	44,822
Average Volume	57,893
Open	28,650
Previous Close	28,800
Day's Range	27,500 - 28,950
52-Week Range	27,450 - 77,200
Beta	n/a
RSI	26.46
Earnings Date	May 26, 2026

About Humedix

Humedix Co., Ltd., a healthcare company, researches, develops, manufactures, and sells various pharmaceutical products in South Korea. It offers over-the-counter drugs, prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic products, and functional synthetic materials, as well as health functional foods. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. The company was founded in 2002 and is headquartered in Anyang-si, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 200670

Financial Performance

In 2021, Humedix's revenue was 110.99 billion, an increase of 12.70% compared to the previous year's 98.48 billion. Earnings were 9.06 billion, a decrease of -39.91%.